CD44 and neoplasm: Ishimoto et al. firstly found that the CD44 variant (CD44v) could stabilize the xCT subunit of the system xc– (cystine-glutamate transporter) to regulate the redox state of gastric cancer cells, therefore promoting tumor growth (45).